Virtu Financial’s ClearPoint Neuro CLPT Stock Holding History

Virtu Financial’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,290	Closed	-$182K	–	1538
2025 Q1	$182K	Sell	15,290 -5,286	-26%	-$82.2K	0.01%	833
2024 Q4	$316K	Buy	+20,576	New	+$267K	0.02%	677
2024 Q3	–	Sell	-19,572	Closed	-$105K	–	1443
2024 Q2	$105K	Buy	+19,572	New	+$113K	0.01%	819
2024 Q1	–	Sell	-12,858	Closed	-$87K	–	1493
2023 Q4	$87K	Buy	+12,858	New	+$72.8K	0.01%	1058
2020 Q4	–	Sell	-19,944	Closed	-$109K	–	1478
2020 Q3	$109K	Buy	+19,944	New	+$87.9K	0.02%	706

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Virtu Financial's CLPT Position: Q2 2025 in Review

Virtu Financial sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 15,290 shares — an estimated $182K sold.

Virtu Financial first reported a position in CLPT in Q3 2020 and held it in 5 quarters. The position peaked at $316K in Q4 2024. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

Virtu Financial reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
Virtu Financial sold 15,290 ClearPoint Neuro shares in Q2 2025, an estimated $182K.
Virtu Financial first reported a position in ClearPoint Neuro in Q3 2020 and held it in 5 quarters.
Virtu Financial's ClearPoint Neuro position peaked at $316K in Q4 2024.
96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.